Assignee
HANMI PHARM IND CO LTD
US·125 granted patents·113 pending applications·867 citations·filing 1995–2022
Top patents by PatentIndex Score
238 records- 0198US10370426B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Aug 6, 2019·21 cites·16 claims
- 0296US7736653B2Pharmaceutical composition comprising an immunoglobulin Fc region as a carrierHANMI PHARM IND CO LTD·Filed 2004·Granted Jun 15, 2010·80 cites·13 claims
- 0396US7737260B2Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI PHARM IND CO LTD·Filed 2004·Granted Jun 15, 2010·54 cites·45 claims
- 0493US11292786B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Apr 5, 2022·4 cites·7 claims
- 0593US10918736B2Conjugate of therapeutic enzymesHANMI PHARM IND CO LTD·Filed 2017·Granted Feb 16, 2021·8 cites·25 claims
- 0693US10894089B2Long-acting insulin or insulin analogue conjugateHANMI PHARM IND CO LTD·Filed 2016·Granted Jan 19, 2021·18 cites·15 claims
- 0793US10400020B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Sep 3, 2019·10 cites·24 claims
- 0892US11667688B2Glucagon derivative and a composition comprising a long acting conjugate of the sameHANMI PHARM IND CO LTD·Filed 2022·Granted Jun 6, 2023·1 cites·18 claims
- 0992US5589455ACyclosporin-containing soft capsule compositionsHANMI PHARM IND CO LTD·Filed 1995·Granted Dec 31, 1996·156 cites·14 claims
- 1090US11332508B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted May 17, 2022·2 cites·34 claims
- 1190US9394546B2Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the sameHANMI PHARM IND CO LTD·Filed 2014·Granted Jul 19, 2016·8 cites·13 claims
- 1290US9220704B2Composite formulation comprising a tablet encapsulated in a hard capsuleHANMI PHARM IND CO LTD·Filed 2012·Granted Dec 29, 2015·7 cites·11 claims
- 1389US11746137B2Immunostimulating IL-2 analogsHANMI PHARM IND CO LTD·Filed 2021·Granted Sep 5, 2023·2 cites·1 claims
- 1488US10696725B2Glucagon derivative and a composition comprising a long acting conjugate of the sameHANMI PHARM IND CO LTD·Filed 2016·Granted Jun 30, 2020·3 cites·27 claims
- 1588US9901621B2Composition for treating hyperlipidemia comprising oxyntomodulin derivativeHANMI PHARM IND CO LTD·Filed 2016·Granted Feb 27, 2018·5 cites·15 claims
- 1688US9724420B2Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC regionHANMI PHARM IND CO LTD·Filed 2013·Granted Aug 8, 2017·9 cites·27 claims
- 1787US10280154B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 7, 2019·4 cites·18 claims
- 1887US6423846B1High-yield method for preparing lansoprazoleHANMI PHARM IND CO LTD·Filed 2001·Granted Jul 23, 2002·18 cites·7 claims
- 1987US6039981AAntifungal oral composition containing itraconazole and process for preparing sameHANMI PHARM IND CO LTD·Filed 1999·Granted Mar 21, 2000·82 cites·5 claims
- 2086US10981967B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted Apr 20, 2021·3 cites·41 claims
- 2185US11389508B2Protein complex by use of a specific site of an immunoglobulin fragment for linkageHANMI PHARM IND CO LTD·Filed 2016·Granted Jul 19, 2022·2 cites·20 claims
- 2285US11261227B2Glucagon derivative and a composition comprising a long acting conjugate of the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Mar 1, 2022·1 cites·9 claims
- 2385US10519141B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·11 claims
- 2485US6444796B1Method of preparing form II crystals of clarithromycinHANMI PHARM IND CO LTD·Filed 2000·Granted Sep 3, 2002·22 cites·9 claims
- 2584US10870639B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·6 claims
- 2684US10660940B2Preparation method for high-yield production of physiologically active polypeptide conjugateHANMI PHARM IND CO LTD·Filed 2014·Granted May 26, 2020·4 cites·28 claims
- 2784US10550168B2Composition for treating diabetes or diabesity comprising oxyntomodulin analogHANMI PHARM IND CO LTD·Filed 2018·Granted Feb 4, 2020·3 cites·10 claims
- 2884US9801950B2Liquid formulation of long acting insulinotropic peptide conjugateHANMI PHARM IND CO LTD·Filed 2013·Granted Oct 31, 2017·7 cites·26 claims
- 2983US11207383B2Protein complex by use of a specific site of an immunoglobulin fragment for linkageHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 28, 2021·2 cites·22 claims
- 3082US11717577B2Method for preparing long-acting drug conjugate through preparation of intermediateHANMI PHARM IND CO LTD·Filed 2019·Granted Aug 8, 2023·2 cites·5 claims
- 3182US10493132B2Composition for treating hyperlipidemia comprising oxyntomodulin derivativeHANMI PHARM IND CO LTD·Filed 2017·Granted Dec 3, 2019·2 cites·6 claims
- 3282US10046061B2Site-specific insulin conjugateHANMI PHARM IND CO LTD·Filed 2014·Granted Aug 14, 2018·6 cites·30 claims
- 3382US7718399B2Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragmentHANMI PHARM IND CO LTD·Filed 2004·Granted May 18, 2010·6 cites·19 claims
- 3482US7157576B2Crystalline acid salts of cefdinir and process for preparing cefdinir using sameHANMI PHARM IND CO LTD·Filed 2002·Granted Jan 2, 2007·12 cites·9 claims
- 3581US10279041B2Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin fragmentHANMI PHARM IND CO LTD·Filed 2017·Granted May 7, 2019·2 cites·23 claims
- 3681US9833516B2Liquid formulation of long-acting insulin and insulinotropic peptideHANMI PHARM IND CO LTD·Filed 2013·Granted Dec 5, 2017·5 cites·30 claims
- 3781US7470707B2Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparationHANMI PHARM IND CO LTD·Filed 2004·Granted Dec 30, 2008·13 cites·10 claims
- 3880US10435459B2Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver diseaseHANMI PHARM IND CO LTD·Filed 2019·Granted Oct 8, 2019·2 cites·13 claims
- 3980US7704709B2Modified human granulocyte-colony stimulating factor and process for producing sameHANMI PHARM IND CO LTD·Filed 2007·Granted Apr 27, 2010·2 cites·28 claims
- 4080US2022213164A1Triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 4179US10159715B2Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugateHANMI PHARM IND CO LTD·Filed 2015·Granted Dec 25, 2018·3 cites·21 claims
- 4279US9931406B2Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricantHANMI PHARM IND CO LTD·Filed 2017·Granted Apr 3, 2018·2 cites·18 claims
- 4379US9388165B2Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2013·Granted Jul 12, 2016·6 cites·13 claims
- 4479US5603951ACyclosporin-containing soft capsule compositionsHANMI PHARM IND CO LTD·Filed 1995·Granted Feb 18, 1997·52 cites·19 claims
- 4578US10487128B2Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the sameHANMI PHARM IND CO LTD·Filed 2014·Granted Nov 26, 2019·2 cites·13 claims
- 4677US10987424B2Liquid formulation of long-acting insulin conjugateHANMI PHARM IND CO LTD·Filed 2013·Granted Apr 27, 2021·1 cites·26 claims
- 4777US10160770B2Method for preparing thienopyrimidine compound and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 25, 2018·1 cites·4 claims
- 4877US9283218B2Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredientHANMI PHARM IND CO LTD·Filed 2013·Granted Mar 15, 2016·3 cites·20 claims
- 4977US7576219B2Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing sameHANMI PHARM IND CO LTD·Filed 2006·Granted Aug 18, 2009·2 cites·1 claims
- 5076US10973881B2IgG4 Fc fragment comprising modified hinge regionHANMI PHARM IND CO LTD·Filed 2014·Granted Apr 13, 2021·1 cites·12 claims
Showing the top 50 of 238 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when HANMI PHARM IND CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →